300406 Stock Overview
Provides in-vitro diagnostics products and services in the People’s Republic of China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Beijing Strong Biotechnologies,Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥14.46 |
| 52 Week High | CN¥21.78 |
| 52 Week Low | CN¥11.01 |
| Beta | 0.38 |
| 1 Month Change | -3.47% |
| 3 Month Change | 27.96% |
| 1 Year Change | -28.27% |
| 3 Year Change | -19.13% |
| 5 Year Change | -8.42% |
| Change since IPO | 180.50% |
Recent News & Updates
Recent updates
Cautious Investors Not Rewarding Beijing Strong Biotechnologies,Inc.'s (SZSE:300406) Performance Completely
Dec 02
Is Beijing Strong BiotechnologiesInc (SZSE:300406) A Risky Investment?
Jul 25Benign Growth For Beijing Strong Biotechnologies,Inc. (SZSE:300406) Underpins Its Share Price
Jul 03An Intrinsic Calculation For Beijing Strong Biotechnologies,Inc. (SZSE:300406) Suggests It's 40% Undervalued
Jun 14Is Now The Time To Put Beijing Strong BiotechnologiesInc (SZSE:300406) On Your Watchlist?
Mar 21Improved Earnings Required Before Beijing Strong Biotechnologies,Inc. (SZSE:300406) Stock's 25% Jump Looks Justified
Mar 03Estimating The Fair Value Of Beijing Strong Biotechnologies,Inc. (SZSE:300406)
Feb 27Shareholder Returns
| 300406 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | -2.0% | -4.9% | -3.5% |
| 1Y | -28.3% | -17.6% | 10.9% |
Return vs Industry: 300406 underperformed the CN Biotechs industry which returned -17.6% over the past year.
Return vs Market: 300406 underperformed the CN Market which returned 10.9% over the past year.
Price Volatility
| 300406 volatility | |
|---|---|
| 300406 Average Weekly Movement | 7.7% |
| Biotechs Industry Average Movement | 8.8% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 300406 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300406's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 1,094 | Xi Liu | www.bsbe.com.cn |
Beijing Strong Biotechnologies,Inc. provides in-vitro diagnostics products and services in the People’s Republic of China and internationally. The company offers biochemistry reagents, including liver, renal, lipid, cardiac, diabetes, special protein, tumor marker, pancreas, inorganic, inflammation, TDM, and other panels; and coagulation products, such as prothrombin time, activated partial thromboplastin time, thrombin time, and fibrinogen, as well as antithrombin III, von Willebrand factor antigen, protein s activity, protein c, lupus anticoagulant, fibrin degradation products, and d-dimer.
Beijing Strong Biotechnologies,Inc. Fundamentals Summary
| 300406 fundamental statistics | |
|---|---|
| Market cap | CN¥8.44b |
| Earnings (TTM) | CN¥525.81m |
| Revenue (TTM) | CN¥1.75b |
16.0x
P/E Ratio4.8x
P/S RatioIs 300406 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300406 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.75b |
| Cost of Revenue | CN¥418.61m |
| Gross Profit | CN¥1.33b |
| Other Expenses | CN¥800.92m |
| Earnings | CN¥525.81m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.90 |
| Gross Margin | 76.02% |
| Net Profit Margin | 30.13% |
| Debt/Equity Ratio | 29.4% |
How did 300406 perform over the long term?
See historical performance and comparisonDividends
1.4%
Current Dividend Yield22%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 02:14 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Beijing Strong Biotechnologies,Inc. is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shuchang Liu | Changjiang Securities Co. LTD. |
| Mingrui Wang | Everbright Securities Co. Ltd. |
| Wenxin Yu | Haitong International Research Limited |